Skip to content

Advertisement

  • Poster presentation
  • Open Access

A novel mutation in NLRC4 in a large pedigree with an anakinra responsive autoinflammatory disease

  • N Volker-Touw1,
  • H de Koning2,
  • T van Kempen3,
  • K Oberndorff4,
  • M van Steensel5,
  • J Giltay1,
  • M Boes6,
  • C de Kovel1,
  • A Simon7,
  • J Frenkel7, 8 and
  • M van Gijn1
Pediatric Rheumatology201513(Suppl 1):P30

https://doi.org/10.1186/1546-0096-13-S1-P30

Published: 28 September 2015

Keywords

Immunohistochemical StainingSkin BiopsyClinical PhenotypeExome SequencingRecurrent Episode

Introduction

Autoinflammatory disorders (AID) are characterized by chronic or recurrent systemic inflammation associated with various clinical presentations. It is a genetically heterogeneous group of diseases. Recently, gain of function mutations in NLRC4 have been described to be associated with autoinflammatory disease. Here, we report a novel NLRC4 mutation in a large pedigree with an anakinra responsive autoinflammaotry disease.

Objective

To identify the genetic defect causing an anakinra responsive autoinflammatory syndrome in a large pedigree.

Patients and methods

We performed whole exome sequencing in the members of a large 6 generation pedigree with an autoinflammatory disease, characterized by recurrent episodes of urticarial skin rash, joint pain and/or swelling, irritation of the eyes, and fatigue. Data with regards to the clinical phenotype were collected retrospectively from the medical charts. Functional studies in monocytes, and histology and immunohistochemical staining in skin biopsies obtained from lesional and uninvolved skin of three patients are currently being performed.

Results

No mutations were detected in the 20 autoinflammatory associated genes known at the time. Exome sequencing revealed a novel p.Ser445Pro variant in NLRC4.The p.Ser445Pro variant segregated with the 13 affected family members. Prediction software programs (Sift, Polyphen) indicate the variant has pathogenic properties. Moreover the variant is located next to the recently described p.His443Pro pathogenic mutation. In all affected family members, the clinical phenotype was influenced by weather conditions, stress, and infection. Severity of the clinical phenotype varied considerably. Moreover, in a subset of the patients, the clinical symptoms resolved promptly after anakinra treatment, indicating involvement of interleukin-1 while other other patients only partially responded to anakinra. Biopsies of lesional skin showed a neutrophilic infiltrate in the dermis. Functional studies in monocytes, and immunohistochemical staining in skin biopsies obtained from lesional and uninvolved skin of patients will provide more insight in the functional effects of the identified NLRC4 variant.

Conclusions

In this study we identify and describe a novel variant in NLRC4 in a large pedigree with an partially anakinra responsive autoinflammatory syndrome, and expanded the clinical phenotype associated with NLRC4-inflammasome mediated autoinflammatory disease.

Authors’ Affiliations

(1)
University Medical Centre Utrecht, Medical Genetics, Utrecht, Netherlands
(2)
Department of Dermatology, Radboud University Medical Centre, Nijmegen, Netherlands
(3)
Dept. of Rheumatology and Clinical Immunology, Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, Netherlands
(4)
Department of Pediatrics, Orbis Medical Centre, Sittard, Netherlands
(5)
Department of Dermatology, University of Dundee, Dundee, UK
(6)
Dept of Pediatric Immunology and Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, Netherlands
(7)
Department of General Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands
(8)
Department of Pediatrics, University Medical Centre Utrecht, Utrecht, Netherlands

Copyright

© Volker-Touw et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement